Correlation Between Karyopharm Therapeutics and Adagene
Can any of the company-specific risk be diversified away by investing in both Karyopharm Therapeutics and Adagene at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Karyopharm Therapeutics and Adagene into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Karyopharm Therapeutics and Adagene, you can compare the effects of market volatilities on Karyopharm Therapeutics and Adagene and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Karyopharm Therapeutics with a short position of Adagene. Check out your portfolio center. Please also check ongoing floating volatility patterns of Karyopharm Therapeutics and Adagene.
Diversification Opportunities for Karyopharm Therapeutics and Adagene
0.56 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Karyopharm and Adagene is 0.56. Overlapping area represents the amount of risk that can be diversified away by holding Karyopharm Therapeutics and Adagene in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Adagene and Karyopharm Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Karyopharm Therapeutics are associated (or correlated) with Adagene. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Adagene has no effect on the direction of Karyopharm Therapeutics i.e., Karyopharm Therapeutics and Adagene go up and down completely randomly.
Pair Corralation between Karyopharm Therapeutics and Adagene
Given the investment horizon of 90 days Karyopharm Therapeutics is expected to under-perform the Adagene. But the stock apears to be less risky and, when comparing its historical volatility, Karyopharm Therapeutics is 3.1 times less risky than Adagene. The stock trades about -0.65 of its potential returns per unit of risk. The Adagene is currently generating about -0.07 of returns per unit of risk over similar time horizon. If you would invest 227.00 in Adagene on September 25, 2024 and sell it today you would lose (33.00) from holding Adagene or give up 14.54% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Karyopharm Therapeutics vs. Adagene
Performance |
Timeline |
Karyopharm Therapeutics |
Adagene |
Karyopharm Therapeutics and Adagene Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Karyopharm Therapeutics and Adagene
The main advantage of trading using opposite Karyopharm Therapeutics and Adagene positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Karyopharm Therapeutics position performs unexpectedly, Adagene can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Adagene will offset losses from the drop in Adagene's long position.Karyopharm Therapeutics vs. X4 Pharmaceuticals | Karyopharm Therapeutics vs. Hookipa Pharma | Karyopharm Therapeutics vs. Mereo BioPharma Group | Karyopharm Therapeutics vs. Acumen Pharmaceuticals |
Adagene vs. Fate Therapeutics | Adagene vs. Caribou Biosciences | Adagene vs. Karyopharm Therapeutics | Adagene vs. X4 Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.
Other Complementary Tools
Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
Fundamental Analysis View fundamental data based on most recent published financial statements |